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Abstract
AIM: To investigate the possible involvement of Sirtuin 
1 (SIRT1) in rat orthotopic liver transplantation (OLT), 
when Institute Georges Lopez 1 (IGL-1) preservation 
solution is enriched with trimetazidine (TMZ).
METHODS: Male Sprague-Dawley rats were used as 
donors and recipients. Livers were stored in IGL-1 pre-
servation solution for 8h at 4 ℃, and then underwent 
OLT according to Kamada’s cuff technique without 
arterialization. In another group, livers were stored in 
IGL-1 preservation solution supplemented with TMZ, at 
10-6 mol/L, for 8 h at 4 ℃ and then underwent OLT. Rats 
were sacrificed 24 h after reperfusion, and liver and plasma 
samples were collected. Liver injury (transaminase levels), 
mitochondrial damage (glutamate dehydrogenase 
activity) oxidative stress (malondialdehyde levels), and 
nicotinamide adenine dinucleotide (NAD+), the co-
factor necessary for SIRT1 activity, were determined 
by biochemical methods. SIRT1 and its substrates (ac-
FoxO1, ac-p53), the precursor of NAD+, nicotinamide 
phosphoribosyltransferase (NAMPT), as well as the 
phosphorylation of adenosine monophosphate activated 
protein kinase (AMPK), p-mTOR, p-p70S6K (direct 
substrate of mTOR), autophagy parameters (beclin-1, 
LC3B) and MAP kinases (p-p38 and p-ERK) were 
determined by Western blot.
RESULTS: Liver grafts preserved in IGL-1 solution 
enriched with TMZ presented reduced liver injury and 
mitochondrial damage compared with those preserved 
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in IGL-1 solution alone. In addition, livers preserved 
in IGL-1 + TMZ presented reduced levels of oxidative 
stress. This was consistent with enhanced SIRT1 protein 
expression and elevated SIRT1 activity, as indicated by 
decreased acetylation of p53 and FoxO1. The elevated 
SIRT1 activity in presence of TMZ can be attributed to 
the enhanced NAMPT protein and NAD+/NADH levels. 
Up-regulation of SIRT1 was consistent with activation 
of AMPK and inhibition of phosphorylation of mTOR 
and its direct substrate (p-p70S6K). As a consequence, 
autophagy mediators (beclin-1 and LC3B) were over-
expressed. Furthermore, MAP kinases were regulated 
in livers preserved with IGL-1 + TMZ, as they were 
characterized by enhanced p-ERK and decreased p-p38 
protein expression.
CONCLUSION: Our study shows that IGL-1 preservation 
solution enriched with TMZ protects liver grafts from the 
IRI associated with OLT, through SIRT1 up-regulation.
Key words: Sirtuin 1; Ischemia-reperfusion injury; Liver 
transplantation; IGL-1 preservation solution; Trimetazidine
© The Author(s) 2015. Published by Baishideng Publishing 
Group Inc. All rights reserved.
Core tip: Sirtuin 1 (SIRT1) has been implicated in path-
ways associated with ischemia-reperfusion injury (IRI), 
but its role in rat orthotopic liver transplantation has 
not yet been established. In our study, SIRT1 protein 
expression levels and activity increased when Institut 
Georges Lopez 1 (IGL-1) preservation solution was 
supplemented with trimetazidine, which was associated 
with less hepatic injury and mitochondrial damage. The 
increased deacetylation of FoxO1 by SIRT1 agreed with 
less oxidative stress and the activation of the autophagy 
pathway. These findings support the notion that SIRT1 
up-regulation may be an effective strategy for reducing 
IRI and improving liver transplantation outcome.
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INTRODUCTION
Liver ischemia-reperfusion injury (IRI) can cause 
primary graft non-function and may lead to organ 
failure[1,2]. The oxygen deprivation during ischemia 
provokes depletion of cellular energy, whereas the 
subsequent re-oxygenation during reperfusion initia-
tes a cascade of complex pathways, including the 
production of reactive oxygen species (ROS), which 
in part are responsible for the subsequent induction 
of hepatocellular injury. Given the complexity of IRI 
pathophysiology, a more profound knowledge of the 
underlying mechanisms is needed in order to design 
new therapeutic strategies able to minimize its adverse 
effects.
SIRT1 is a histone deacetylase that either acti-
vates or suppresses the transcription activities of 
various non-histone proteins through its nicotinamide 
adenine dinucleotide (NAD+)-dependent activity. 
SIRT1 has been associated with the pathophysiology 
of IRI in several organs[3]. In fact, SIRT1 is involved 
in a wide variety of cellular processes, including 
apoptosis, cellular stress and autophagy[4-7]. It has 
been reported that SIRT1 deacetylates p53, thus 
reducing its transcriptional activity and its ability to 
induce apoptosis[8]. Forkhead box-containing protein 
O 1 (FoxO1) is also a target for SIRT1, and its de-
acetylation has been implicated in the detoxification 
of ROS and the promotion of autophagy[9]. Further-
more, we have recently shown that SIRT1 activation 
contributes, in part, to the protective effects of liver 
ischemic preconditioning against IRI[10].
Adequate liver preservation is vital for the success 
of transplantation, in order to maintain graft quality 
after cold storage. At present, University of Wiscon-
sin (UW) solution is the most widely used preser-
vation solution. Recent studies have demonstrated 
that Institute Georges Lopez 1 (IGL-1) preservation 
solution is a valuable alternative for liver grafts in 
orthotopic liver transplantation (OLT)[11,12]. Moreover, 
supplementation of IGL-1 with trimetazidine (TMZ) 
has been shown to increase the preservation of both 
steatotic and non-steatotic liver grafts in an isolated 
and perfused “ex vivo” model[13]. However, the role of 
SIRT1 in rat OLT when IGL-1 solutions are used has 
not been assessed to date.
Given that TMZ is a promising additive for incre-
asing liver graft preservation and since SIRT1 exerts 
a protective role against warm IRI in the liver, the 
aim of this study is to investigate the potential role 
of SIRT1 in rat OLT when TMZ-enriched IGL-1 pre-
servation solution is used.
MATERIALS AND METHODS
Animals
Male Sprague-Dawley rats (200-250 g) were used as 
donors and recipients. Throughout the study, animals 
were housed in conventional animal facilities where 
temperature and humidity were controlled with a 
12 h light/dark cycle. All animals had free access to 
water and a standard laboratory diet. All procedures 
were performed under isofluorane inhalation ane-
sthesia. The experiments were approved by the 
Ethics Committees for Animal Experimentation (CEEA, 
Directive 400/12), University of Barcelona and all 
procedures complied with European Union regulations 
for animal experiments (EU guideline 86/609/EEC). 
Rats were randomly distributed into groups as de-
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scribed below.
Experimental design
The following experimental groups were created: 
(1) Sham (n = 6): Animals underwent transverse 
laparotomy and received silk ligatures in the right 
suprarenal vein, diaphragmatic vein, and hepatic 
artery; (2) IGL-1 (n = 6): Livers were flushed and 
stored in IGL-1 preservation solution for 8h at 4 ℃, 
and then underwent OLT according to Kamada’s cuff 
technique without arterialization. Rats were sacrificed 
24 h after reperfusion for liver and plasma sample 
collection; and (3) IGL-1 + TMZ (n = 6): Same as 
group 2, but livers were preserved in IGL-1 solution 
supplemented with trimetazidine (TMZ) at 10-6 mol/L.
Transaminase assay
Hepatic injury was assessed in terms of alanine 
aminotransferase (ALT) levels with commercial kits 
from RAL (Barcelona, Spain). Briefly, plasma extracts 
were collected before liver extraction and centrifuged 
at 4 ℃ for 10 min at 0.8 g. Then, 200 μL of the su-
pernatant was added to the substrate provided by 
the commercial kit. ALT levels were determined at 
365 nm with a UV spectrometer (DU 800, Beckman 
Coulter) and calculated following the supplier’s in-
structions[14].
Glutamate dehydrogenase activity
Glutamate dehydrogenase (GLDH) is a mitochondrial 
enzyme that catalyses the conversion of glutamate to 
2-oxoglutarate. It was used as an indirect marker of 
mitochondrial damage; it was measured in plasma, 
as described previously[15].
Lipid peroxidation assay
Lipid peroxidation in the liver was used as an indirect 
measure of the oxidative injury induced by ROS. 
Lipid peroxidation was determined by measuring the 
formation of malondialdehyde (MDA) with the thi-
obarbiturate reaction[16]. Liver samples were homo-
genized in Tris-HCL pH = 7 and 250 μL of trichloroacetic 
acid (TCA) were added to 250 μL of liver homogenates. 
Then, the samples were centrifugated in 3000 rpm 
at 4 ℃ for 15 min. Then, 250 μL of thiobarbituric acid 
(TBA) were added to the supernatant and were heated 
at 100 ℃ for 30 min. MDA reacted with TBA to form 
a pink chromogenic compound whose absorbance at 
540 nm was measured. The result was expressed as 
nmols/mg protein.
NAD+/NADH determination
NAD+/NADH from liver were quantified with a com­
mercially available kit (MAK037, Sigma Chemical, 
St. Louis, MO, United States) according to the manu-
facturer’s instructions.
Western blot analysis
Liver tissue was homogenized in HEPES buffer as 
previously described[10]. Fifty μg of proteins was 
separated on 8%-15% SDS-PAGE gels and trans-
blotted on PVDF membranes (Bio-Rad). Membranes 
were then blocked for one hour with 5% (w/v) non-
fat milk in T-TBS and incubated overnight at 4 ℃ 
with antibody against SIRT1 (#07-131), p-mTOR 
(Ser2481, #09-343), mTOR (#04-385), all purchased 
from Merck Millipore, Billerica, MA; ac-p53 (ab37318, 
abcam, United kingdom); ac-FoxO1 (D-19, sc-49437), 
BECN1 (H-300, sc-11427), both purchased from Santa 
Cruz Biotechnology Inc, CA, United States; p-AMPK 
(Thr172, #2535), p-p38 mitogen activated protein (MAP) 
kinase (Thr180/Tyr182,#9211), p-70S6K (Thr389, 
#9205), LC3B (#2775), p-p44/42 MAPK (Erk1/2, 
Thr202/Tyr204), #9101, all from Cell Signaling, 
Danvers, MA, NAMPT (AP22021SU, Acris Antibodies 
GmbH, Germany), HSP70 (610607, Transduction Labo-
ratories, Lexington, KY) and b-actin (A5316, Sigma 
Chemical, St. Louis, MO, United States). Membranes 
were then incubated for 1 h at room temperature with 
the corresponding secondary antibody linked to hor-
seradish peroxidase. Bound complexes were detected 
using WesternBright ECL-HRP substrate (Advansta, 
Barcelona, Spain) and were quantified using the Quan­
tity One software for image analysis. Results were 
expressed as the densitometric ratio between the pro-
tein of interest and the loading control (b-actin).
Statistical analysis
Data are expressed as mean ± SE. Statistical com-
parison was performed by variance analysis, followed 
by the Student-Newman-Keuls test (Graft Pad prism 
software). P < 0.05 was considered significant.
RESULTS
Liver injury and mitochondrial damage
We first determined liver and mitochondrial injury 
through transaminase and GLDH levels respectively in 
the different experimental groups. Livers preserved in 
IGL-1 and subjected to OLT showed the highest ALT 
and GLDH levels, whereas addition of TMZ to the IGL-1 
solution resulted in a significant decrease in liver and 
mitochondrial injury in comparison with IGL-1 solution 
alone (Figure 1).
SIRT1, NAMPT, ac-p53 ac-FoxO1 proteins expression 
and NAD+ levels
In order to explore the potential involvement of 
SIRT1 in the protective effects of TMZ on rat OLT, we 
first determined its protein expression pattern. SIRT1 
protein expression was significantly increased when 
livers were preserved in IGL-1 solution compared 
with the Sham group (Figure 2C). Interestingly, the 
addition of TMZ to IGL-1 solution clearly enhanced 
SIRT1 expression compared with IGL-1 solution alone 
(Figure 2C). In view of the altered SIRT1 protein 
levels, we then investigated parameters associated 
with SIRT1 activity, such as the protein expression of 
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nicotinamide phosphoribosyltransferase (NAMPT), the 
NAD+/NADH levels, as well as the acetylation state of 
two direct substrates, p53 and FoxO1. As shown in 
Figure 2A, liver graft preservation in IGL-1 solution led 
to high NAMPT protein expression, which was further 
enhanced in case of IGL-1 supplemented with TMZ. 
Furthermore, NAD+/NADH levels were significantly 
reduced in both IGL-1 groups in comparison to non-
treated animals (Figure 2B). However, the presence 
of TMZ in IGL-1 resulted in a better preservation 
of NAD+/NADH levels than the IGL-1 alone (Figure 
2B). This was consistent with decreased acetylated 
FoxO1 and p53 protein levels in IGL-1 + TMZ group 
compared with IGL-1 (Figure 2D and Figure 2E re-
spectively). These results suggest an increase in 
SIRT1 activity in the IGL-1 + TMZ group; therefore, 
the protective effect of TMZ is exerted, at least in 
part, through the induction of both SIRT1 expression 
and activation.
Oxidative stress and HSP70 protein expression
Next, we evaluated lipid peroxidation as an indicator 
of oxidative stress in OLT. Livers preserved in IGL-1 
solution showed significantly increased MDA com-
pared with Sham (Figure 3A). This increase was 
prevented by the addition of TMZ in IGL-1 solution. 
Moreover, livers preserved in IGL-1 solution up-regu-
lated the levels of the cytoprotective heat shock pro-
tein 70 (HSP70), which was further enhanced in the 
presence of TMZ (Figure 3B).
p-AMPK and p-mTOR activation
It is known that both AMP-activated protein kinase 
(AMPK) and SIRT1 regulate each other and share 
many common target molecules[17]. We therefore 
assessed the possible involvement of AMPK activation 
in the protective effects of TMZ. As shown in Figure 
4A, livers preserved with IGL-1 solution showed 
increased phosphorylated AMPK (p-AMPK). However, 
this AMPK activation was further enhanced in the 
presence of TMZ. Given that the mammalian target 
of rapamycin (mTOR) activity is regulated by AMPK, 
we next evaluated both phosphorylated mTOR (p-
mTOR) and mTOR protein levels as well as the pho-
sphorylation levels of its direct substrate, p-p70S6K. 
As shown in Figure 4B and C, the addition of TMZ to 
IGL-1 solution significantly reduced p-mTOR/mTOR 
and p-p70S6k protein levels compared with IGL-1 
preservation solution alone.
Autophagy: Beclin-1 and LC3B protein levels
Autophagy is a conserved cellular process that is 
activated under conditions of nutrient stress to pro-
mote cell survival. Given the importance of the mTOR 
signaling pathway in the suppression of autophagy[18] 
and the fact that IGL-1 preservation solution enriched 
with TMZ was characterized by inactivation of both 
mTOR and p70S6k protein, we sought to test whether 
TMZ-induced SIRT1 protective effects might be 
mediated through the activation of autophagy. To do 
so, we explored the expression of beclin-1 and LC3B, 
two well-known proteins involved in the autophagic 
pathway. Both proteins presented significant up-
regulation in the IGL-1 + TMZ group compared with 
both Sham and IGL-1 group (Figure 5A, B).
MAP kinases
Finally, we explored the modulation of MAP kinases by 
TMZ. Here we observed increased phosphorylation of 
extracellular signal-regulated kinase (ERK) in IGL-1 
preserved livers, which was further enhanced when 
TMZ was added to the preservation solution (Figure 
6A). Moreover, the presence of TMZ in IGL-1 solution 
reversed the increased phosphorylation of p38 protein 
levels detected in the livers preserved in IGL-1 solution 
(Figures 6B and 7).
DISCUSSION
The present study provides the first evidence that 
SIRT1 up-regulation in a rat model of OLT contributes 
to a better preservation of liver grafts against IRI. 
SIRT1 over-expression is attributed to the use of a 
modified IGL-1 preservation solution enriched with 
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TMZ, an anti-ischemic drug administered for the 
treatment of angina pectoris[19]. In earlier work with 
an isolated perfused rat liver model, we already 
showed that TMZ addition to IGL-1 solution promotes 
cytoprotective markers that are induced during is-
chemia, such as hypoxia inducible factor-1α through 
nitric oxide generation, as well as those promoted 
during reperfusion, such as heme oxygenase-1[13]. 
Here, we report that the addition of TMZ in IGL-1 
preservation solution favors the activation of SIRT1 in 
rat OLT.
The increases observed in SIRT1 protein levels 
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were consistent with an effective prevention of liver 
injury and mitochondrial damage. We previously 
reported the protective effect of TMZ on liver damage 
after graft preservation, and showed that its addition 
to UW solution reduces liver injury and improves liver 
function[20]. Our current data confirm that SIRT1 up­
regulation in OLT due to TMZ can be considered as a 
protective cellular signaling response against IRI. This 
finding corroborates previous reports of a protective 
effect for SIRT1 against IRI in different organs such 
as heart, kidney and brain[21-23].
SIRT1 over-expression in liver grafts preserved in 
IGL-1 + TMZ was concomitant with increased levels 
of both NAMPT and NAD+. NAD+ is a cofactor required 
for SIRT1 enzymatic activity. Furthermore, it has been 
shown that NAMPT is the rate-limiting enzyme in the 
NAD+ biosynthetic pathway and directly regulates 
SIRT1 activity in mammalian cells[24]. NAMPT up-
regulation has been shown to be beneficial against 
cardiac IRI through preservation of NAD+ levels and 
SIRT1 regulation[25]. Taking this into account, we 
suggest that in the IGL-1 + TMZ group the increased 
NAMPT protein levels promote NAD+ production, which 
in turn contributes to the high SIRT1 deacetylase 
activity. Indeed, in the same group we observed de-
creased levels of acetylated p53 and FoxO1, two di-
rect substrates of SIRT1, which have been reported 
to be SIRT1 activity markers[26,27]. Therefore, the TMZ 
protective effects observed are mediated, at least in 
part, by enhanced SIRT1 activity.
SIRT1 plays an important role in cellular stress, 
including the oxidative stress associated with IRI. 
FoxO1 deacetylation by SIRT1 has been linked with 
the capacity of FoxO1 to enhance the transcription 
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Figure 6  Protein levels of pERK (A) and p-p38 (B) in livers after 24 h of reperfusion. Sham: Liver harvested without transplantation; IGL-1: Liver transplanted 
after 8 h of cold storage in IGL-1 solution; IGL-1 + TMZ: Liver transplanted after 8 h of cold storage in IGL-1 solution with 10-6 mol/L trimetazidine (TMZ). aP < 0.05 vs 
Sham; cP < 0.05 vs IGL-1.
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of anti-oxidant enzymes, thus contributing to the 
resistance against oxidative stress[4,5,21]. For these 
reasons, we decided to explore the potential relation-
ship between SIRT1, ac-FoxO1 and the lipid pero-
xidation that occurs in OLT. In the present study, 
we found that the significant SIRT1 induction and 
FoxO1 deacetylation were accompanied by marked 
decreases in lipid peroxidation when TMZ was added 
to IGL-1. Moreover, SIRT1 up-regulation in OLT may 
contribute to reducing hepatic vulnerability against 
oxidative stress and to improving the mitochondrial 
status during oxidative stress conditions. Our results 
corroborate those of Ou et al[28] who demonstrated 
that over-expression of SIRT1 under oxidative stress 
conditions enhanced mitochondrial function in em-
bryonic stem cells. In addition, Hsu et al[21] demon-
strated that hearts over-expressing SIRT1 were more 
resistant to oxidative stress in response to IRI, due, in 
part, to the effective FoxO1 deacetylation by SIRT1.
It is well known that increases in heat shock protein 
expression are involved in the protection against oxida-
tive stress[29]. Our results also demonstrate strong 
HSP70 protein expression in the IGL-1 + TMZ group. 
This direct connection between SIRT1 and HSP70 
during liver IRI was recently reported by our group in 
liver ischemic preconditioning[10].
Autophagy plays an important role in both sensing 
oxidative stress and removing oxidative damaged 
proteins and organelles[30]. This process involves the 
inhibition of p-mTOR (mammalian TOR) and the sub-
sequent inactivation of its direct substrate, p70S6k[31]. 
During autophagy, specific proteins such as beclin­1 
(in the initial stages of autophagosome formation) 
and LC3B (during autophagosome expansion) are 
activated[32,33]. AMPK activation results in mTOR 
inhibition and subsequent autophagy activation[31]. In 
addition, SIRT1 deacetylase activity has been asso-
ciated with activation of AMPK, and SIRT1- mediated 
deacetylation of FoxO1 has also been implicated in 
increased autophagy[34-36]. In our study, SIRT1 over-
expression and the enhanced activity in the IGL-1 + 
TMZ group was concomitant with AMPK activation, 
reduced levels of p-mTOR/p-p70S6k, and increased 
autophagy (beclin­1 and LC3B). Our findings are in 
agreement with other investigations carried out in 
liver[37-39] and kidney[40] which have shown the pro-
tective effect of autophagy against IRI. Autophagy 
activation through a NAMPT/SIRT1-dependent me-
chanism has also been shown to be protective against 
cerebral ischemia[41].
However, the role of autophagy in IRI has been 
controversial, as various studies have evidenced 
either a beneficial or detrimental role. For example 
Jiang et al[40] have reported a renoprotective role of 
autophagy against IRI; during ischemia, autophagy 
can contribute to the provision of nutrients, whereas 
during reperfusion can eliminate damaged proteins 
and organelles. Similarly, Matsui et al[42] in cardiac 
IRI showed that autophagy was protective during 
ischemia, but beclin-1 dependent autophagy acti-
vation during reperfusion was associated with cell 
death. Autophagy is stimulated by various factors and 
it still remains unknown which steps determine the 
decision for the survival or death. Between them, the 
time of ischemia seems to influence the autophagy 
outcome, as a prolonged ischemia time can result in 
excessive activation of autophagy and subsequently 
to cell death[43]. In our case, autophagy is associated 
with decreased graft injury and thus we may suppose 
that eight hours of cold preservation is not sufficient 
1772 February 14, 2015|Volume 21|Issue 6|WJG|www.wjgnet.com
TRZ ↑SIRT1↑NAD↑NAMPT
Mitochondrial damage 
(GLDH)
Oxidative stress 
(MDA)
Autophagy activation 
↓pmTOR/p70S6K
↑beclin-1, LC3B
MAPK regulation 
↑p-ERK
↓p-p38
↓IRI
Figure 7  Schematic model of the protective effect of sirtuin 1 against ischemia-reperfusion injury associated to rat orthotopic liver transplantation. 
Trimetazidine (TMZ) addition to IGL-1 promotes NAMPT expression and enhances NAD+ levels, which in turn provokes SIRT1 up-regulation. SIRT1 contributes to 
decreased hepatic injury by inhibiting mitochondrial damage and oxidative stress, activating autophagic pathway and by enhancing p-ERK and decreasing p-p38 
protein expression. SIRT1: Sirtuin 1; IRI: Ischemia-reperfusion injury; OLT: Orthotopic liver transplantation.
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time for an excessive and detrimental activation of 
autophagy. More profound investigations are required 
in order to define the regulatory mechanisms of 
autophagy.
In a recent publication, we reported that SIRT1 
modulates (MAP) kinases, whose activation is a con-
sequence of oxidative stress generation associated 
to IRI[16]. Here, we show that TMZ addition to IGL-1 
enhances p-ERK protein levels and reduces p-p38 
protein levels in comparison to IGL-1 alone. As a 
result, the increased SIRT1 over-expression in OLT 
coincided with the modulation of the MAP kinases, as 
reported in other studies[44].
Taken together, our results show that TMZ exerts 
its protective role against IRI associated with OLT, 
in part, through the induction of SIRT1 protein ex-
pression and activity. We found that SIRT1 up-regu-
lation prevented liver injury and oxidative stress and 
promoted liver autophagy (see Figure 7). Our findings 
support the benefits of pharmacological activation of 
SIRT1, a new therapeutic strategy for improving liver 
graft preservation.
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of mechanisms. However, SIRT1 involvement in models of transplantation has 
not been determined to date. The present study evaluated the potential role of 
SIRT1 in a rat OLT model. SIRT1 was up-regulated when livers were stored in 
IGL + TMZ preservation solution and helped to improve the protection of liver 
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